Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: A cross-sectional analysis

American Journal of Kidney Diseases

Volumn 56, Issue 5, 2010, Pages 883-895

  Meijer, Esther ^a   Boertien, Wendy E ^a   Nauta, Ferdau L ^a   Bakker, Stephan J L ^a   Van Oeveren, Wim ^a   Rook, Mieneke ^a   Van Der Jagt, Eric J ^a   Van Goor, Harry ^a   Peters, Dorien J M ^b   Navis, Gerjan ^a   De Jong, Paul E ^a   Gansevoort, Ron T ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

albuminuria; Autosomal dominant polycystic kidney disease; disease severity; heart type fatty acid binding protein; immunoglobulin G; Index Words; kidney injury molecule 1; macrophage migration inhibitory factor; monocyte chemotactic protein 1; N acetyl d glucosaminidase; neutrophil gelatinase associated lipocalin; polycystic kidney disease

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN; IMMUNOGLOBULIN G; KIDNEY INJURY MOLECULE 1; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACETYLGLUCOSAMINIDASE; ACUTE PHASE PROTEIN; FABP3 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ADULT; AGE DISTRIBUTION; ALBUMINURIA; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE SEVERITY; EFFECTIVE RENAL BLOOD FLOW; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY PROXIMAL TUBULE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RENAL SYSTEM PARAMETERS; SEX DIFFERENCE; TOTAL RENAL VOLUME; URINALYSIS; URINARY EXCRETION; COMPARATIVE STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; NETHERLANDS; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PREVALENCE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; URINE;

ACETYLGLUCOSAMINIDASE; ACUTE-PHASE PROTEINS; ADULT; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOGLOBULIN G; LIPOCALINS; MALE; NETHERLANDS; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PREVALENCE; PROGNOSIS; PROTO-ONCOGENE PROTEINS; SEVERITY OF ILLNESS INDEX;

EID: 77958456505     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.06.023     Document Type: Article

References (47)

1. V.E. Torres, P.C. Harris, and Y. Pirson Autosomal dominant polycystic kidney disease Lancet 369 9569 2007 1287 1301
2. B.Y. Reed, K. McFann, and M.R. Bekheirnia Variation in age at ESRD in autosomal dominant polycystic kidney disease Am J Kidney Dis 51 2 2008 173 183
3. R. Schrier, K. McFann, and A. Johnson Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study J Am Soc Nephrol 13 7 2002 1733 1739
4. M.A. van Dijk, M.H. Breuning, R. Duiser, L.A. van Es, and R.G. Westendorp No effect of enalapril on progression in autosomal dominant polycystic kidney disease Nephrol Dial Transplant 18 11 2003 2314 2320
5. E. Meijer, P.E. de Jong, D.J. Peters, and R.T. Gansevoort Better understanding of ADPKD results in potential new treatment options: ready for the cure? J Nephrol 21 2 2008 133 138
6. V.E. Torres, and P.C. Harris Autosomal dominant polycystic kidney disease: the last 3 years Kidney Int 76 2 2009 149 168
7. J.J. Grantham, A.B. Chapman, and V.E. Torres Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes Clin J Am Soc Nephrol 1 1 2006 148 157
8. B.F. King, V.E. Torres, and M.E. Brummer Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease Kidney Int 64 6 2003 2214 2221
9. V.E. Torres, B.F. King, and A.B. Chapman Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease Clin J Am Soc Nephrol 2 1 2007 112 120
10. J.J. Grantham, V.E. Torres, and A.B. Chapman Volume progression in polycystic kidney disease N Engl J Med 354 20 2006 2122 2130
11. M.M. van Timmeren, V.S. Vaidya, and R.M. van Ree High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients Transplantation 84 12 2007 1625 1630
12. F. Waanders, M.M. van Timmeren, C.A. Stegeman, S.J. Bakker, and H. van Goor Kidney injury molecule-1 in renal disease J Pathol 220 1 2010 7 16
13. U. Lebkowska, J. Malyszko, and A. Lebkowska Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study Transplant Proc 41 1 2009 154 157
14. D. Dimitrakov, E. Kumchev, E. Lyutakova, and L. Grigorov Glomerular hyperfiltration and serum beta 2-microglobulin used as early markers in diagnosis of autosomal dominant polycystic kidney disease Folia Med (Plovdiv) 35 1-2 1993 59 62
15. N. Birenboim, V.S. Donoso, R.A. Huseman, and J.J. Grantham Renal excretion and cyst accumulation of beta 2microglobulin in polycystic kidney disease Kidney Int 31 1 1987 85 92
16. D. Bolignano, G. Coppolino, and S. Campo Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease Am J Nephrol 27 4 2007 373 378
17. D. Zheng, M. Wolfe, B.D. Cowley Jr, D.P. Wallace, T. Yamaguchi, and J.J. Grantham Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease J Am Soc Nephrol 14 10 2003 2588 2595
18. P.J. Azurmendi, A.R. Fraga, and F.M. Galan Early renal and vascular changes in ADPKD patients with low-grade albumin excretion and normal renal function Nephrol Dial Transplant 24 8 2009 2458 2463
19. A.B. Chapman, L.M. Guay-Woodford, and J.J. Grantham Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort Kidney Int 64 3 2003 1035 1045
20. A.B. Chapman, A.M. Johnson, P.A. Gabow, and R.W. Schrier Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease J Am Soc Nephrol 5 6 1994 1349 1354
21. Tolvaptan Efficacy and Safety in Management of Polycystic Kidney Disease and its outcomes (TEMPO 3/4) http://clinicaltrials.gov/ct2/show/NCT00428948? term=tempo&rank=1 Accessed September 1, 2010
22. A.B. Maunsbach Absorption of I-125-labeled homologous albumin by rat kidney proximal tubule cells A study of microperfused single proximal tubules by electron microscopic autoradiography and histochemistry J Ultrastruct Res 15 3 1966 197 241
23. S. Cui, P.J. Verroust, S.K. Moestrup, and E.I. Christensen Megalin/gp330 mediates uptake of albumin in renal proximal tubule Am J Physiol 271 4, pt 2 1996 F900 F907
24. D. Ravine, R.N. Gibson, R.G. Walker, L.J. Sheffield, P. Kincaid-Smith, and D.M. Danks Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1 Lancet 343 8901 1994 824 827
25. R.J. Trof, F. Di Maggio, J. Leemreis, and A.B. Groeneveld Biomarkers of acute renal injury and renal failure Shock 26 3 2006 245 253
26. C.R. Parikh, and P. Devarajan New biomarkers of acute kidney injury Crit Care Med 36 4 suppl 2008 S159 S165
27. R.G. Maatman, T.H. Van Kuppevelt, and J.H. Veerkamp Two types of fatty acid-binding protein in human kidney Isolation, characterization and localization Biochem J 273 pt 3 1991 759 766
28. J.M. Hofstra, J.K. Deegens, E.J. Steenbergen, and J.F. Wetzels Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy Nephrol Dial Transplant 23 10 2008 3160 3165
29. A.M. Kuusniemi, R. Lapatto, C. Holmberg, R. Karikoski, J. Rapola, and H. Jalanko Kidneys with heavy proteinuria show fibrosis, inflammation, and oxidative stress, but no tubular phenotypic change Kidney Int 68 1 2005 121 132
30. K. Matsumoto, N. Maruyama, and T. Maruyama Elevated macrophage migration inhibitory factor (MIF) levels in the urine of patients with focal glomerular sclerosis Clin Exp Immunol 139 2 2005 338 347
31. H.Y. Lan Role of macrophage migration inhibition factor in kidney disease Nephron Exp Nephrol 109 3 2008 e79 e83
32. G. Grandaliano, L. Gesualdo, and F. Bartoli MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy Kidney Int 58 1 2000 182 192
33. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group Ann Intern Med 130 6 1999 461 470
34. A.J. Donker, G.K. van der Hem, W.J. Sluiter, and H. Beekhuis A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow Neth J Med 20 3 1977 97 103
35. 131I-hippuran J Am Soc Nephrol 7 4 1996 567 572
36. R. Zietse, P.J. Blankestijn, and B. Pos Optimising glomerular filtration rate and effective renal plasma flow measurements using a simple pharmacokinetic model Clin Nephrol 43 1 1995 29 34
37. W.M. Michels, D.C. Grootendorst, K. Rozemeijer, F.W. Dekker, and R.T. Krediet Glomerular filtration rate measurements by (125)I-iothalamate should be corrected for inaccurate urine collections with (131)I-hippuran Clin Nephrol 72 5 2009 337 343
38. K.T. Bae, P.K. Commean, and J. Lee Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease J Comput Assist Tomogr 24 4 2000 614 619
39. V.E. Torres Vasopressin antagonists in polycystic kidney disease Kidney Int 68 5 2005 2405 2418
40. E.W. Kuehn, K.M. Park, S. Somlo, and J.V. Bonventre Kidney injury molecule-1 expression in murine polycystic kidney disease Am J Physiol Renal Physiol 283 6 2002 F1326 F1336
41. T. Nakamura, T. Sugaya, Y. Kawagoe, Y. Ueda, S. Osada, and H. Koide Candesartan reduces urinary fatty acid-binding protein excretion in patients with autosomal dominant polycystic kidney disease Am J Med Sci 330 4 2005 161 165
42. B.D. Cowley Jr, S.D. Ricardo, S. Nagao, and J.R. Diamond Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats Kidney Int 60 6 2001 2087 2096
43. J.A. Casal, J. Hermida, X.M. Lens, and J.C. Tutor A comparative study of three kidney biomarker tests in autosomal-dominant polycystic kidney disease Kidney Int 68 3 2005 948 954
44. T. Ichimura, E.J. Asseldonk, B.D. Humphreys, L. Gunaratnam, J.S. Duffield, and J.V. Bonventre Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells J Clin Invest 118 5 2008 1657 1668
45. E.W. Kuehn, M.N. Hirt, and A.K. John Kidney injury molecule 1 (Kim1) is a novel ciliary molecule and interactor of polycystin 2 Biochem Biophys Res Commun 364 4 2007 861 866
46. F. Kotsis, R. Nitschke, C. Boehlke, M. Bashkurov, G. Walz, and E.W. Kuehn Ciliary calcium signaling is modulated by kidney injury molecule-1 (Kim1) Pflugers Arch 453 6 2007 819 829
47. F. Wei, A. Karihaloo, and Z. Yu Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo Kidney Int 74 10 2008 1310 1318